NPPA issued a notification regarding the fixation of the retail price of Empagliflozin 12.5 mg + Metformin Hydrochloride IP 500 mg for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) and M/s Aristo Pharmaceuticals Pvt. Ltd. (Marketer)

Feb 20, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on February 19, 2025, issued a notification regarding the fixation of the retail price of Empagliflozin 12.5 mg + Metformin Hydrochloride IP 500 mg for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) and M/s Aristo Pharmaceuticals Pvt. Ltd. (Marketer).

The following has been stated: -

• Each Film Coated Tablet Contains: Empagliflozin 12.5 mg + Metformin Hydrochloride IP 500 mg for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) and M/s Aristo Pharmaceuticals Pvt. Ltd. (Marketer) the retail price is 36.19 (Rs)


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT